Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial

INTRODUCTION: Fatigue is one of the most disabling symptoms associated with fibromyalgia that greatly impacts quality of life. Fatigue was assessed as a secondary objective in a 2-phase, 24-week study in outpatients with American College of Rheumatology-defined fibromyalgia. METHODS: Patients were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Lesley M, Wang, Fujun, Ahl, Jonna, Gaynor, Paula J, Wohlreich, Madelaine M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218901/
https://www.ncbi.nlm.nih.gov/pubmed/21668963
http://dx.doi.org/10.1186/ar3359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218901/
https://www.ncbi.nlm.nih.gov/pubmed/21668963
http://dx.doi.org/10.1186/ar3359

Ejemplares similares